PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Adalimumab - Behcet's syndrome
PAD Profile : Adalimumab - Behcet's syndrome Important
Brand Names Include :
Humira, Hyrimoz, Imraldi, Amgevita, Hulio, Yuflyma, Idacio
Important Information :
Highly specialist centres only.
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
Other Indications
- Ankylosing spondylitis
- Inflammatory bowel disease
- Psoriasis
- Psoriasis (Hand and foot)
- Psoriatic arthritis
- Rheumatoid arthritis
- Non-radiographic axial spondyloarthritis
- Localised Psoriasis
- Non-infectious uveitis
Additional Documents
No additional documents returned.
Committee Recommendations
No committee recommendations returned.
Associated BNF Codes
10. Musculoskeletal and Joint Diseases
10.01.03. Rheumatic disease suppressant drugs